| Code | 5708E | ||||||||||
| MA number | 44/0048/24-S | ||||||||||
| Product Form: | cps mol 60x1x100 mg (blis.OPA/Al/PVC/Al - jednotk.bal.) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister OPA/Al/PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 18.03.2024 |
| Validity: | 18.03.2029 |
| SPC: |
SPC_Nintedanib Teva_03_2024.pdf
|
| PIL: |
PIL_Nintedanib Teva 100 mg mäkké kapsuly_03_2024.pdf
|
| Safety feature | Yes |
| Data update: | 25.03.2024 |
